Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Nerisone (Diflucortolone-valerate).
Absorption: Prolonged use of Nerisone (Diflucortolone-valerate) over large areas of the body or under dressings that don't breathe can cause diflucortolone to be absorbed into the bloodstream. This may result in side effects similar to those seen after taking a corticosteroid by mouth for long periods of time (e.g., Depression, filling or rounding out of the face, increased blood pressure, increased blood sugar, irritability, loss of appetite, rapid weight gain or loss, stomach bloating, or swelling of feet or lower legs).
Allergy: Stop using Nerisone (Diflucortolone-valerate) and contact your doctor immediately if you notice signs of an allergic reaction, such as increased irritation or itchiness.
Circulation problems: Poor circulation may increase the risk of developing infections or developing sensitivity to Nerisone (Diflucortolone-valerate). If you have poor circulation or leg ulcers because of poor circulation, discuss with your doctor how Nerisone (Diflucortolone-valerate) may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Nerisone (Diflucortolone-valerate), and whether any special monitoring is needed.
Infections: Diflucortolone should not be used on any area of infected skin. Corticosteroids applied to the skin may increase the risk of developing a skin infection. If you notice any increased redness, swelling, heat, or pain around the area where the medication is applied, contact your doctor, as these are possible signs of infection.
Long-term use: Long-term use of Nerisone (Diflucortolone-valerate) may cause skin thinning, abnormal growth of facial hair, and acne. If these side effects occur, stop using Nerisone (Diflucortolone-valerate) and contact your doctor immediately. If you do not notice improvement in your skin condition after 2 to 4 weeks, contact your doctor.
Proper use: Diflucortolone should not be used over large areas with dressings that do not breathe or for prolonged periods of time, unless directed by your doctor. Nerisone (Diflucortolone-valerate) should not be used in or near the eye or around the mouth area. Application near the eye may increase the risk of developing Cataracts or Glaucoma.
Thinning of skin: Prolonged use of topical corticosteroid products may produce thinning of the skin and of tissues under it. If you notice this, call your doctor.
Pregnancy: Nerisone (Diflucortolone-valerate) should not be used during pregnancy unless the benefits outweigh the risks. Contact your doctor immediately if you become pregnant while taking Nerisone (Diflucortolone-valerate).
Breast-feeding: It is not known if diflucortolone passes into breast milk. If you are a breast-feeding mother and are taking Nerisone (Diflucortolone-valerate), it may affect your baby. Talk to your doctor about whether you should continue breast-feeding.
Children: The safety and effectiveness of using Nerisone (Diflucortolone-valerate) have not been established for children. Children are more likely to experience absorption of topical corticosteroids and the side effects that occur with absorbed corticosteroids. Nerisone (Diflucortolone-valerate) is not intended to be used for children less than 12 months of age.